Canagliflozin reduces chemoresistance in hepatocellular carcinoma through PKM2-c-Myc complex-mediated glutamine starvation

Y Zeng, H Jiang, X Zhang, J Xu, X Wu, Q Xu… - Free Radical Biology …, 2023 - Elsevier
Cisplatin (CPT) is one of the standard treatments for hepatocellular carcinoma (HCC).
However, its use is limits as a monotherapy due to drug resistance, and the underlying …
被引用次数：6 相关文章

Canagliflozin reduces chemoresistance in hepatocellular carcinoma through PKM2-c-Myc complex-mediated glutamine starvation

Y Zeng, H Jiang, X Zhang, J Xu, X Wu… - Free radical biology … - pubmed.ncbi.nlm.nih.gov
Cisplatin (CPT) is one of the standard treatments for hepatocellular carcinoma (HCC).
However, its use is limits as a monotherapy due to drug resistance, and the underlying …

Canagliflozin reduces chemoresistance in hepatocellular carcinoma through PKM2-c-Myc complex-mediated glutamine starvation.

Y Zeng, H Jiang, X Zhang, J Xu, X Wu, Q Xu… - Free Radical Biology …, 2023 - europepmc.org
Cisplatin (CPT) is one of the standard treatments for hepatocellular carcinoma (HCC).
However, its use is limits as a monotherapy due to drug resistance, and the underlying …